Sponsor Check › Person
Related person on Form D filings · address states as listed: MA, NY, NJ, PA, MN, OH, CA · listed Oct 1, 2009 → Sep 25, 2023
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
4 of 26 offerings report sales commissions totalling $2,598,264; 0 report finder's fees; 2 report proceeds to related persons totalling $4,167,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | May 7, 2026 D File 021-583141 | $0 | $0 | $0 (est.) Excludes standard compensation for officers and directors. | None listed on this filing |
| EDGAR ↗ | Oct 31, 2025 D File 021-562697 | $0 | $0 | $0 (est.) Excludes standard compensation for officers and directors. | None listed on this filing |
| EDGAR ↗ | Aug 6, 2025 D File 021-553915 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 30, 2024 D File 021-525382 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 4, 2024 D File 021-509640 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Nov 6, 2023 D/A File 021-479709 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 25, 2023 D File 021-492968 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 11, 2023 D/A File 021-352647 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 2, 2023 D File 021-472445 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 19, 2022 D File 021-467959 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 29, 2021 D File 021-427005 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 15, 2021 D File 021-386466 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 3, 2020 D File 021-379524 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 29, 2020 D File 021-379259 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 3, 2018 D File 021-318473 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 8, 2016 D File 021-273998 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 22, 2016 D File 021-271108 | $660,000 (est.) | $0 | $0 | Rockport Venture Securities, LLC BrokerCheck CRD 113748 ↗ |
| EDGAR ↗ | Dec 3, 2015 D File 021-252351 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 19, 2014 D File 021-230541 | $840,000 | $0 | $0 | Leerink Partners LLC BrokerCheck CRD 39011 ↗ via Leerink Partners LLC (CRD 39011 ↗) |
| EDGAR ↗ | Aug 28, 2013 D File 021-202003 | $448,264 (est.) | $0 | $0 | Liberty Tree Advisors, LLC BrokerCheck CRD 143679 ↗ |
| EDGAR ↗ | Jan 7, 2013 D File 021-189629 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 7, 2011 D/A File 021-117510 | $0 | $0 | $2,500,000 (est.) | Sanders Morris Harris Inc. BrokerCheck CRD 20580 ↗ via Sanders Morris Harris Inc. (CRD 20580 ↗) |
| EDGAR ↗ | Feb 7, 2011 D/A File 021-117511 | $0 | $0 | $1,667,000 (est.) | Sanders Morris Harris Inc. BrokerCheck CRD 20580 ↗ via Sanders Morris Harris Inc. (CRD 20580 ↗) |
| EDGAR ↗ | Jan 4, 2011 D File 021-152948 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 22, 2010 D File 021-152391 | $650,000 | $0 | $0 | Maxim Group, LLC BrokerCheck CRD 120708 ↗ Sanders Morris Harris Inc. BrokerCheck CRD 20580 ↗ |
| EDGAR ↗ | Apr 9, 2010 D File 021-35299-8N | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Miach Orthopaedics Inc. | Director | May 7, 2026 | D | $6,500,000 similar: $829,831–$9,999,998 | $6,500,000 | 14 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Miach Orthopaedics Inc. | Director | Oct 31, 2025 | D | $15,000,000 similar: $829,831–$9,999,998 | $7,500,000 | 14 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Neuros Medical, Inc. | Director | Aug 6, 2025 | D | $64,999,994 similar: $2,000,000–$19,999,994 | $55,999,997 | 28 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ShiraTronics, Inc | Director | Sep 30, 2024 | D | $66,008,867 similar: $2,000,000–$19,999,994 | $37,396,117 | 30 similar: 2–16 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | Miach Orthopaedics Inc. | Director | Apr 4, 2024 | D | $20,000,000 similar: $829,831–$9,999,998 | $20,000,000 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | GYNESONICS, INC | Director | Nov 6, 2023 | D/A | $92,184,203 similar: $829,831–$9,999,998 | $92,184,203 | 13 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Neuros Medical, Inc. | Director | Sep 25, 2023 | D | $20,000,431 similar: $2,000,000–$19,999,994 | $20,000,000 | 41 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ShiraTronics, Inc | Director | Aug 11, 2023 | D/A | $42,147,461 similar: $2,000,000–$19,999,994 | $41,689,951 | 11 similar: 2–16 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | GYNESONICS, INC | Director | Apr 21, 2023 | D | $65,000,000 similar: $829,831–$9,999,998 | $49,499,998 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Miach Orthopaedics Inc. | Director | Feb 2, 2023 | D | $40,304,967 similar: $829,831–$9,999,998 | $40,304,967 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Neuros Medical, Inc. | Director | Dec 19, 2022 | D | $10,000,000 similar: $2,000,000–$19,999,994 | $8,229,699 | 40 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | GYNESONICS, INC | Director | Dec 29, 2021 | D | $50,000,000 similar: $829,831–$9,999,998 | $32,502,239 | 18 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Impulse Dynamics plc | Director | Jan 15, 2021 | D | $60,000,000 similar: $2,000,000–$19,999,994 | $60,000,000 | 4 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Neuros Medical, Inc. | Director | Nov 3, 2020 | D | $42,777,148 similar: $2,000,000–$19,999,994 | $36,981,418 | 24 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Impulse Dynamics plc | Director | Oct 29, 2020 | D | $45,250,000 similar: $2,000,000–$19,999,994 | $45,250,000 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ShiraTronics, Inc | Director | Mar 27, 2020 | D/A | $36,647,464 similar: $2,000,000–$19,999,994 | $14,886,609 | 10 similar: 2–16 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | ShiraTronics, Inc | Director | Nov 5, 2019 | D | $35,647,461 similar: $2,000,000–$19,999,994 | $13,659,335 | 9 similar: 2–16 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | Essential Medical, Inc. group: Essential | Director | Aug 3, 2018 | D | $10,000,000 similar: $829,831–$9,999,998 | $6,000,000 | 36 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Inspire Medical Systems, Inc. | Director | Nov 8, 2016 | D | $37,500,000 similar: $829,831–$9,999,998 | $12,500,000 | 22 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Essential Medical, Inc. group: Essential | Director Joined Board as of 9-9-16 | Sep 22, 2016 | D | $15,000,000 similar: $829,831–$9,999,998 | $14,810,000 | 27 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Icon Bioscience, Inc. | Director | Dec 3, 2015 | D | $9,821,504 similar: $1,694,259–$16,000,000 | $5,316,245 | 18 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | KEW Group Inc. | Director | Dec 19, 2014 | D | $16,798,000 similar: $2,000,000–$19,999,994 | $16,798,000 | 40 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Icon Bioscience, Inc. | Director | Aug 28, 2013 | D | $20,000,000 similar: $1,694,259–$16,000,000 | $14,906,669 | 8 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | IGI LABORATORIES, INC | Director | Jan 7, 2013 | D | $2,000,000 similar: $1,694,259–$16,000,000 | $2,000,000 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS QP PARTNERSHIP II LP group: Signet Healthcare | Executive Officer | Feb 7, 2011 | D/A | $128,635,468 similar: $155,000–$5,250,000 | $128,635,468 | 82 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP group: Signet Healthcare | Executive Officer | Feb 7, 2011 | D/A | $128,635,662 similar: $155,000–$5,250,000 | $128,635,662 | 90 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | IGI LABORATORIES, INC | Director | Jan 4, 2011 | D | $8,813 similar: $1,694,259–$16,000,000 | $8,813 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | IGI LABORATORIES, INC | Director | Dec 22, 2010 | D | $6,600,000 similar: $1,694,259–$16,000,000 | $6,500,000 | 78 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP group: Signet Healthcare | Executive Officer | Jun 25, 2010 | D/A | $200,000,000 similar: $155,000–$5,250,000 | $55,463,000 | 59 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS QP PARTNERSHIP II LP group: Signet Healthcare | Executive Officer | Jun 25, 2010 | D/A | $200,000,000 similar: $155,000–$5,250,000 | $116,513,000 | 59 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | IGI LABORATORIES, INC | Director | Apr 9, 2010 | D | $1,550,000 similar: $1,694,259–$16,000,000 | $1,550,000 | 13 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS QP PARTNERSHIP II LP group: Signet Healthcare | Executive Officer | Nov 12, 2009 | D/A | $200,000,000 similar: $155,000–$5,250,000 | $105,363,000 | 61 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP group: Signet Healthcare | Executive Officer | Oct 1, 2009 | D/A | $200,000,000 similar: $155,000–$5,250,000 | $55,363,000 | 59 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
| EDGAR ↗ | SIGNET HEALTHCARE PARTNERS QP PARTNERSHIP II LP group: Signet Healthcare | Executive Officer | Oct 1, 2009 | D/A | $200,000,000 similar: $155,000–$5,250,000 | $55,363,000 | 59 similar: 4–27 | $50,000 similar: $1,000–$100,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Biotechnology / 506(b) (3,253 filings); Pharmaceuticals / 506(b) (800 filings); Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Joyce Erony. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Joyce Erony appears on a new Form D, or when a court case or SEC action is matched to them. See plans →